Trimethadione 150 mg Chewable Tablet
RxNorm 198330
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 198330 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: trimethadione 150 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Trimethadione 150 mg Chewable Tablet
(Atom ID: 12324382)
FN
Full form of descriptor (FN):
Product containing precisely trimethadione 150 mg/1 each conventional release chewable tablet (clinical drug)
(Atom ID: 11440874)
PSN
Prescribable Name (PSN):
Trimethadione 150 mg Chewable Tablet
(Atom ID: 6370249)
PT
Designated preferred name (PT):
Trimethadione 150 mg chewable tablet
(Atom ID: 11441564)
Patient Education
Trimethadione
Trimethadione is used to control absence seizures (petit mal; a type of seizure in which there is a very short loss of awareness during which the person may stare straight ahead or blink his eyes and does not respond to others) when other medications will not work. Trimethadione is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.